Peptide record

TPDB05048

Vasoactive intestina Vasoactive intestinal peptide Antibacterial Anticancer Antifungal Antiparasitic Antiviral Blood-Brain Barrier Cell-penetrating Peptides Neuropeptide Toxicity standard
28 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05048
Vasoactive intestina Vasoactive intestinal peptide
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Blood-Brain Barrier Cell-penetrating Peptides Neuropeptide Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides Neuroactive peptides
AntiBP3 dbAMP Peptipedia AFP-GFuse Antifungipept CAFPdb i2APP AI4AVP B3Pred BBPpredict CPPsite3.0 ToxinPred 3.0
standard
No
A 28-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
HSDAVFTDNYTRLRKQMAVKKYLNSILN
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C147H237N43O43S1
CEGPW
NLK
3326.82
10.22
6
2
12
+3
2.48
-0.639
83.57
Mammalian: 3.5 hour Yeast: 10 min E.coli: >10 hour
2980
0.90
10
Residue Composition
number
2
A
2
R
3
N
2
D
0
C
0
E
1
Q
0
G
1
H
1
I
3
L
3
K
1
M
1
F
0
P
2
S
2
T
0
W
2
Y
2
V
Amino Acid Distribution
A: 2 R: 2 N: 3 D: 2 C: 0 E: 0 Q: 1 G: 0 H: 1 I: 1 L: 3 K: 3 M: 1 F: 1 P: 0 S: 2 T: 2 W: 0 Y: 2 V: 2
Chemical Descriptors
28 reviewed residue count
C147H237N43O43S1 sequence-only estimate (linear, free termini)
3326.82 sequence-only estimate (linear, free termini)
10.22 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
2.48 sequence-only estimate (linear, free termini)
-0.639 sequence-only estimate (linear, free termini)
Linear Activity
His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn Activity
CCC(C)C(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(N)CC1=CN=CN1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(N)=O Activity
Evidence Records 18 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
0.0004 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Intravenous
non saturable
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.00028 ml/g

Assay & Model

Initial distribution volume

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Intravenous
Permeability
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
0.00216 mL/(g x min)

Assay & Model

Unidirectional flux rate constant

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
in situ brain perfusion
non saturable
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
86.6 %/g

Assay & Model

HPLC
% injected dose

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Direct iodination
Evidence 5 Activity

Activity

Blood-Brain Barrier
69.8 %/g

Assay & Model

HPLC
% injected dose

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Direct iodination
Evidence 6 Activity

Activity

Blood-Brain Barrier
72.2 %/g

Assay & Model

HPLC
% injected dose

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Direct iodination
Evidence 7 Activity

Activity

Blood-Brain Barrier
-2.19

Assay & Model

Shake Flask
Log P

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Direct iodination
Evidence 8 Activity

Activity

Neuropeptide

Target

Pituitary adenylate cyclase-activating polypeptide type I receptor
Bos taurus

Source & Reference

NA
NeuroPepV2

Other

Bos taurus
Glucagon
513
NP04401 NP04415 NP04424 NP04450 NP04376 NP04463
Evidence 9 Activity

Activity

Neuropeptide

Source & Reference

NA
NeuroPepV2

Other

Canis lupus familiaris
Glucagon
Evidence 10 Activity

Activity

Neuropeptide

Source & Reference

NA
NeuroPepV2

Other

Capra hircus
Glucagon
Evidence 11 Activity

Activity

Neuropeptide

Target

Vasoactive intestinal polypeptide receptor 1 Vasoactive intestinal polypeptide receptor 2
Homo sapiens Homo sapiens

Source & Reference

NA
NeuroPepV2

Other

Homo sapiens
Glucagon
457 438
NP04418 NP04427 NP04470 NP04418 NP04427 NP04470
Evidence 12 Activity

Activity

Neuropeptide

Source & Reference

NA
NeuroPepV2

Other

Macaca mulatta
Glucagon
Evidence 13 Activity

Activity

Neuropeptide

Target

Vasoactive intestinal polypeptide receptor 1 Vasoactive intestinal polypeptide receptor 2
Mus musculus Mus musculus

Source & Reference

NA
NeuroPepV2

Other

Mus musculus
Glucagon
459 437
NP04473 NP04419 NP04428 NP04473
Evidence 14 Activity

Activity

Neuropeptide

Target

Vasoactive intestinal polypeptide receptor 1
Sus scrofa

Source & Reference

NA
NeuroPepV2

Other

Sus scrofa
Glucagon
458
NP04476
Evidence 15 Activity

Activity

Neuropeptide

Source & Reference

NA
NeuroPepV2

Other

Oryctolagus cuniculus
Glucagon
Evidence 16 Activity

Activity

Neuropeptide

Target

Vasoactive intestinal polypeptide receptor 1 Vasoactive intestinal polypeptide receptor 2
Rattus norvegicus Rattus norvegicus

Source & Reference

NA
NeuroPepV2

Other

Rattus norvegicus
Glucagon
459 437
NP04478 NP04422 NP04431 NP04478
Evidence 17 Activity

Activity

Neuropeptide

Source & Reference

NA
NeuroPepV2

Other

Ovis aries
Glucagon
Evidence 18 Activity

Activity

10% Cell death
Toxicity
100 µg/mL
Cytotoxic
10% Cell death | 100 | µg/mL | target cell: Human pulp fibroblasts

Target

Human pulp fibroblasts

Source & Reference

NA
DBAASP
Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. | J Neuroimmunol | 2008
Additional Detail Fields 4 fields
Glucagon
Intravenous in situ brain perfusion
513 457 438 459 437 458
NP04401 NP04415 NP04424 NP04450 NP04376 NP04463 NP04418 NP04427 NP04470 NP04473 NP04419 NP04428 NP04476 NP04478 NP04422 NP04431